Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up. - Veerapandiyan, Aravindhan; Bourke, John; Soslow, Jonathan H.; Day, John W.; McDonald, Craig M.; Mendell, Jerry R.; Zaidman, Craig M.; Mason, Stefanie; Meng, Jianfeng; Vivien, Mark; Murphy, Alexander P.; Wandel, Christoph; et al. (Cardiology & Therapy, 2026)